Skip to content
healthcare.dev
Get a free key

Abrysvo

NDC 0069-2465, Respiratory Syncytial Virus Vaccine, injection, powder, lyophilized, for solution, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-2465
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125769
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-2465 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN.06 mg/.5mL
  • RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN.06 mg/.5mL
Package NDCNDC-11Package
0069-2465-01000692465011 VIAL in 1 CARTON (0069-2465-01) / .5 mL in 1 VIAL (0069-2465-19)
0069-2465-100006924651010 VIAL in 1 CARTON (0069-2465-10) / .5 mL in 1 VIAL (0069-2465-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0069-2465 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-2465 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-2465. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.